← back to search
Chunlei Ke
Amgen (United States) · US
Area of research
Oncology · Statistics and Probability
Research interest
Research interests include Medicine, Zoledronic acid, Denosumab, Oncology, Internal medicine, and Proteinuria.
h-index
—
citations
670
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases
Kidney International Reports
2023
cited by
83
position: middle
doi
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
European Journal of Cancer
2012
cited by
587
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
—
·
1
papers (2012–2012)
David H. Henry
· Pennsylvania Hospital
1
papers (2012–2012)
Yiwei Zhang
· China Institute of Atomic Energy
1
papers (2023–2023)
Michael Clemens
· Klinikum Saarbrücken
1
papers (2012–2012)
Susie Jun
· Gilead Sciences (United States)
1
papers (2012–2012)
Ada Braun
· Amgen (United States)
1
papers (2012–2012)
Michael Rader
· Amgen (United States)
1
papers (2012–2012)
Allan Lipton
· Pennsylvania State University
1
papers (2012–2012)
Li Li
· Jiangsu University
1
papers (2023–2023)
Liwei Huang
· Shanxi Medical University
1
papers (2023–2023)
Karim Fizazi
· Institut Gustave Roussy
1
papers (2012–2012)
Alison Stopeck
· University of Arizona
1
papers (2012–2012)
Gary Richardson
· Cabrini Hospital
1
papers (2012–2012)
—
·
1
papers (2023–2023)
—
·
1
papers (2012–2012)
Denise A. Yardley
· Lublin Oncology Center
1
papers (2012–2012)
Philippe Beuzeboc
· Université Paris Sciences et Lettres
1
papers (2012–2012)
Salvatore Siena
· Metropolitana Milanese (Italy)
1
papers (2012–2012)
Veena Charu
· California Pacific Medical Center
1
papers (2012–2012)
Larry A. Greenbaum
· Emory University
1
papers (2023–2023)